Subclinical Renal Dysfunction in Rheumatoid Arthritis
Assessment of Subclinical Renal Dysfunction in Rheumatoid Arthritis and Its Association With Disease Activity
1 other identifier
observational
120
0 countries
N/A
Brief Summary
This comparative cross-sectional study aims to determine the prevalence of subclinical renal dysfunction in patients with rheumatoid arthritis and to evaluate its association with disease activity and inflammatory markers compared with age- and sex-matched healthy controls at Assiut University Hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
September 9, 2026
September 1, 2026
1 year
September 1, 2026
September 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of subclinical renal dysfunction
Proportion of participants with subclinical renal dysfunction, defined as the presence of reduced estimated glomerular filtration rate (eGFR \< 90 mL/min/1.73 m²) and/or elevated urine albumin-to-creatinine ratio (UACR ≥ 30 mg/g) in the absence of previously diagnosed chronic kidney disease.
Baseline
Secondary Outcomes (5)
Comparison of eGFR between groups
Baseline
Comparison of UACR between groups
Baseline
Correlation of subclinical renal dysfunction with disease activity
Baseline
Correlation of subclinical renal dysfunction with inflammatory markers
Baseline
Independent predictors of subclinical renal dysfunction
Baseline
Study Arms (2)
Rheumatoid arthritis patients (n=80)
Adult patients diagnosed with rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria attending the Rheumatology outpatient clinic and inpatient wards at Assiut University Hospitals.
Healthy controls (n=40)
Age- and sex-matched apparently healthy individuals with no history of autoimmune disease or chronic kidney disease.
Eligibility Criteria
Adult patients with rheumatoid arthritis attending the Rheumatology outpatient clinic and inpatient wards at Assiut University Hospitals, and age- and sex-matched healthy controls.
You may qualify if:
- Age 18 years or older
- For patient group: Diagnosis of rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria
- For control group: Age- and sex-matched apparently healthy individuals with no history of autoimmune disease or chronic kidney disease
- Willingness to provide written informed consent
You may not qualify if:
- Known chronic kidney disease
- Acute kidney injury
- Diabetes mellitus
- Uncontrolled hypertension
- Active urinary tract infection
- Pregnancy
- History of obstructive uropathy or renal stones
- Systemic lupus erythematosus or other connective tissue diseases
- Malignancy
- Patients on maintenance hemodialysis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Boers M, Dijkmans BA, Breedveld FC, Camps JA, Chang PC, van Brummelen P, Pauwels EK, Cats A. Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum. 1990 Jan;33(1):95-101. doi: 10.1002/art.1780330113.
PMID: 2302273BACKGROUNDPedersen LM, Nordin H, Svensson B, Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis. 1995 Mar;54(3):189-92. doi: 10.1136/ard.54.3.189.
PMID: 7748016BACKGROUNDDaoussis D, Panoulas VF, John H, Toms TE, Antonopoulos I, Treharne G, Nightingale P, Douglas KM, Kitas GD. Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol. 2011 Apr;30(4):477-84. doi: 10.1007/s10067-010-1446-y. Epub 2010 Apr 16.
PMID: 20396921BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Essam m abd elaziz, prof
Internal Medicine Department, Assiut University Hospitals, Assiut, Egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- An internal medicine resident physician
Study Record Dates
First Submitted
September 1, 2026
First Posted
September 4, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
September 9, 2026
Record last verified: 2026-09